Heliox-Driven Racemic Epinephrine in Treatment of Bronchiolitis in Pediatric ED Patients
Status:
Completed
Trial end date:
2011-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess whether children with moderate to severe bronchiolitis
treated with standard racemic epinephrine therapy via 70:30 helium-oxygen (heliox) driven
nebulization will have improvements in measurements of airway more rapidly than those treated
with conventional air-oxygen driven nebulization.